Vietnam Medical and Pharmaceutical Investment JSC (HOSE:JVC)
Vietnam · Delayed Price · Currency is VND 3,050.00
0.00 (0.00%)
At close: Aug 13, 2026
HOSE:JVC Financials Overview
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 |
Revenue Revenue Growth | 747,221 | 763,153 | 611,540 | 576,287 | 499,432 | 507,338 |
Revenue Growth | 14.41% | 24.79% | 6.12% | 15.39% | -1.56% | -43.20% |
Gross Profit Gross Profit Growth | 165,277 | 148,917 | 147,572 | 138,863 | 93,981 | 3,386 |
Operating Income Operating Income Growth | 63,037 | 52,796 | 36,510 | 27,308 | -26,745 | -1,192,003 |
Net Income Net Income Growth | 50,780 | 49,945 | 40,282 | 52,634 | -31,694 | -1,335,782 |
Earnings Per Share EPS Growth | 451.38 | 443.96 | 358.00 | 467.86 | -281.73 | -11873.60 |
EPS Growth | -2.81% | 24.01% | -23.48% | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 |
Providing Services Providing Services Growth | 59,619 | 50,691 |
Medical Device Integration Activities Medical Device Integration Activities Growth | 29,097 | 67,729 |
Sale of Medical Machinery and Equipment Sale of Medical Machinery and Equipment Growth | 674,437 | 493,120 |
Total Total Growth | 763,153 | 611,540 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 |
Cash & Investments Cash & Investments Growth | 146,949 | 29,228 | 19,582 | 153,516 | 37,500 | 16,557 |
Total Debt Total Debt Growth | 225,198 | 303,082 | 140,829 | 92,726 | 35,721 | 51,611 |
Net Cash (Debt) Net Cash Growth | -78,249 | -273,854 | -121,247 | 60,790 | 1,778 | -35,054 |
Net Cash Growth | - | - | - | 3318.23% | - | - |
Net Cash Per Share Net Cash Per Share Growth | -695.55 | -2434.25 | -1077.75 | 540.36 | 15.81 | -311.59 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 |
Operating Cash Flow Operating Cash Flow Growth | 259,699 | -88,546 | 85,753 | -6,474 | 76,126 | -319,023 |
Capital Expenditures CapEx Growth | -20,451 | -41,862 | -16,594 | -43,363 | -42,587 | -8,810 |
Free Cash Flow Free Cash Flow Growth | 239,248 | -130,408 | 69,159 | -49,837 | 33,540 | -327,834 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 |
Gross Margin | 22.12% | 19.51% | 24.13% | 24.10% | 18.82% | 0.67% |
Operating Margin | 8.44% | 6.92% | 5.97% | 4.74% | -5.36% | -234.95% |
Pretax Margin | 8.38% | 8.05% | 9.63% | 9.70% | -5.94% | -263.34% |
Profit Margin | 6.80% | 6.54% | 6.59% | 9.13% | -6.35% | -263.29% |
FCF Margin | 32.02% | -17.09% | 11.31% | -8.65% | 6.72% | -64.62% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 |
PE Ratio | 6.76 | 13.72 | 10.61 | 7.22 | - | - |
Forward PE | - | 9.64 | 9.64 | 9.64 | 9.64 | 9.64 |
P/FCF Ratio | 1.43 | - | 6.18 | - | 11.64 | - |
PS Ratio | 0.46 | 0.90 | 0.70 | 0.66 | 0.78 | 1.02 |